Evidence map›Paper›PMID 39251934›Full record

ArticleBMC genomics2024

Biallelic TYR and TKFC variants in Egyptian patients with OCA1 and new expanded TKFC features.

Engy A Ashaat, Nora N Esmaiel, Sonia A El-Saiedi, Neveen A Ashaat, Dalia Farouk Hussen, Abeer Ramadan, Mohamed Ahmed Al Kersh, Nirvana S AbdelHakim, Ibrahim Said, Ammal M Metwally and 1 more

Abstract readCase Reports
In one paragraph

Article in BMC genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Engy A AshaatClinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt. ea.ashaat@nrc.sci.eg.ORCID http://orcid.org/0000-0002-2116-1570
Nora N EsmaielMolecular Genetics and Enzymology Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
Sonia A El-SaiediPediatric Cardiology Department, Cairo University, Cairo, Egypt.
Neveen A AshaatProfessor of Genetics, Ain Shams University, Cairo, Egypt.
Dalia Farouk HussenHuman Cytogenetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
Abeer RamadanMolecular Genetics and Enzymology Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
Mohamed Ahmed Al KershOrthopedic Department, Ain Shams University, Cairo, Egypt.
Nirvana S AbdelHakimFetal Medicine Unit, Faculty of Medicine, Cairo University, Cairo, Egypt.
Ibrahim SaidFetal Medicine Unit, Faculty of Medicine, Cairo University, Cairo, Egypt.
Ammal M MetwallyCommunity Medicine Research Department/Medical Research and Clinical Studies Institute, National Research Centre (Affiliation ID: 60014618), Cairo, Egypt. ammal_mok@yahoo.com.
Alaaeldin FayezMolecular Genetics and Enzymology Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOculocutaneous albinism type1 (OCA1) is caused by the TYR gene's homozygous and compound heterozygous variants. TKFC gene variants cause triokinase & FMN cyclase deficiency syndrome with variable multisystemic disorders.

objectivesTo determine the potential disease-causing variants in two deceased patients presenting atypical OCA1 features by demonstrating three generations for a single family. The two deceased neonates had severe skeletal abnormalities and fatal hypertrophic cardiomyopathy. We also explored the potential mechanisms for the causative relationship between TKFC and multisystem disorders. PATIENTS AND

methodsDue to the new emerging symptoms that weren't reported before with the TYR gene, the following methods were performed: Sanger sequencing for the TYR gene, followed by whole exome sequencing, co-segregation, and computational analyses.

resultsExtensive parental consanguinity was found, and consequently an autosomal recessive mode of inheritance was prioritized. Upon performing sequencing and segregation data, the following has been confirmed: positive co-segregation of nonsense homozygous NM_000372.5:c.346C > T p.(Arg116*) variant in TYR gene and multisystem disease-missense homozygous NM_015533.4:c.598G > A p.(Val200Ile) variant in TKFC gene in the two affected index patients who deceased due to hypertrophic cardiomyopathy. Using computational analysis, we found that c.598G > A p.(Val200Ile) pathogenicity has led to the failure of L2-K1 active site closure due to the potential differential fluctuation between valine and isoleucine residues. Subsequently, disruption of endogenous DHA phosphorylation was found. Two potential mechanisms exploring the causative relationship between TKFC gene and multisystem disorders have been suggested.

conclusionsThis study presented a first family with the co-existence of biallelic variants in TYR and TKFC genes associating severe skeletal abnormalities and lethal hypertrophic cardiomyopathy. Neither of these genes would have been pursued in the standard genetic counseling. Such discovery is paving the way for more efficient genetic counseling. Comparing TKFC results with literature data showed that our relevant expanded TKFC variant is the 3rd worldwide.

Indexed as

PedigreeAllelesCardiomyopathy, HypertrophicConsanguinityEgyptFemaleHomozygoteHumansInfant, NewbornMaleMutationBiallelic variantsExpanding the phenotypic TKFC spectrumOculocutaneous albinism (OCA1)TKFCTYR

Identifiers

PMID39251934
PMCPMC11382379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.